Amber Biology Partner, Gordon Webster, has an excellent op-ed on why hiring in R&D can be a big bottleneck to research.
Read MoreThe commercial development of therapeutic antibodies is not without its risks.
Read MoreAmber Biology will be helping NPR bring you the news and other current affairs programs on our local station WBUR which serves the Boston area.
Read MoreScott Berkun’s book “The Myths of Innovation” is a refreshing and unpretentious take on this overused buzzword..
Read MoreThe “round hole” that managing an R&D program presents to the “square peg” that is the traditional management model.
Read More